StructureValidate: Multi-Method Molecular Confirmation Service
A boutique analytical lab service that combines 3-4 complementary secondary methods (NMR, mass spectrometry, IR spectroscopy, computational modeling) into a standardized validation package when primary methods fail. Researchers submit their inconclusive primary data + sample; the lab runs a pre-designed protocol suite, generates a confidence-scored structural report, and provides written justification for publication/regulatory submission.
46 weeks • 70% confidence
Value Proposition
Eliminates 6-12 week delays waiting for beamtime or equipment repair. Provides legally defensible, peer-reviewable validation without researchers needing to master multiple instruments. 40% faster than in-house troubleshooting; confidence scoring removes guesswork on whether secondary data is 'good enough' for publication.
Target Audience
Biotech R&D teams, pharmaceutical companies (50-500 employees), academic chemistry/materials labs with grant funding, contract research organizations (CROs) handling failed crystallography cases
Key Features
- Intake form captures failed primary method details + sample constraints (solubility, stability, quantity)
- Standardized 4-method protocol suite (NMR + LCMS + FTIR + DFT modeling) completed in 10-14 days
- Confidence scoring matrix: each method weighted by relevance to structure type (organic vs. inorganic vs. polymer)
- And more, with full implementation detail...
Tech Stack
Unlock the full solution
You're seeing a preview. Unlock the complete value proposition, every feature, the full tech stack, the monetization model, and the week-by-week build roadmap, plus a downloadable PDF.
Sign up free to continue3 free solution credits on signup
The build plan is behind the wall
Subscribers get the full monetization model, pricing strategy, and the complete week-by-week roadmap to build this.
Sign up freeOriginal Problem
Researchers struggle to reconstruct molecular structures when primary analytical methods are unavailable or failScientists and researchers face critical bottlenecks when their primary structural analysis tools (like x-ray crystallography) are unavailable, damaged, or produce inconclusive results, forcing them to rely on secondary methods that may not provide sufficient evidence for breakthrough discoveries. This creates uncertainty in validating molecular structures and delays drug development, materials research, and scientific publications. Current alternative analytical techniques exist but lack the integration, validation frameworks, and decision-support systems to confidently substitute for primary methods.
Score: 17.5%